Related Experiment Videos
1,25-Dihydroxyvitamin D3 inhibits the clonogenic growth of transformed cells via its receptor
Abstract:
Anchorage-independent growth in soft agar is a unique property of transformed cells which is known to be correlated with tumorigenicity. We report here that 1,25-dihydroxyvitamin D3 suppresses colony formation by a number of cultured cancer cell lines in soft agar in a dose dependent manner with an ID50 of 5-7 X 10(-10) M. This effect is also achieved with analogues of 1,25-dihydroxyvitamin D3 in accordance with their binding affinity for the hormone's receptor. Only cells with 1,25-dihydroxyvitamin D3 receptor protein are inhibited in their colony formation by vitamin D analogs indicating that the hormone receptor complex may be integrally involved in the in vitro suppression of the anchorage-independent phenotype.
Insights
1,25-dihydroxyvitamin D3 effectively suppresses cancer cell growth in soft agar, a key indicator of tumor formation. This vitamin D3 analog
Area of Science:
- Cell Biology
- Molecular Biology
- Endocrinology
Background:
- Anchorage-independent growth in soft agar is a hallmark of cancer cells, correlating with tumorigenicity.
- Understanding factors that inhibit this growth is crucial for cancer therapy development.
Purpose of the Study:
- To investigate the effect of 1,25-dihydroxyvitamin D3 on anchorage-independent growth of cancer cells.
- To determine the role of the 1,25-dihydroxyvitamin D3 receptor in this suppressive effect.
Main Methods:
- Cultured cancer cell lines were treated with varying concentrations of 1,25-dihydroxyvitamin D3 and its analogs.
- Colony formation in soft agar was assessed to measure anchorage-independent growth.
- The presence of the 1,25-dihydroxyvitamin D3 receptor protein was analyzed in the cell lines.
Main Results:
- 1,25-dihydroxyvitamin D3 significantly suppressed soft agar colony formation in a dose-dependent manner (ID50 of 5-7 X 10(-10) M).
- Analogues of 1,25-dihydroxyvitamin D3 showed similar inhibitory effects, correlating with their receptor binding affinity.
- Inhibition was observed exclusively in cell lines expressing the 1,25-dihydroxyvitamin D3 receptor.
Conclusions:
- 1,25-dihydroxyvitamin D3 is a potent suppressor of anchorage-independent cancer cell growth.
- The 1,25-dihydroxyvitamin D3 receptor plays a critical role in mediating the anti-proliferative effects of vitamin D analogs on cancer cells.
- These findings suggest potential therapeutic applications for vitamin D and its analogs in targeting tumorigenicity.